[go: up one dir, main page]

FI940726L - Farmaseuttiset koostumukset - Google Patents

Farmaseuttiset koostumukset Download PDF

Info

Publication number
FI940726L
FI940726L FI940726A FI940726A FI940726L FI 940726 L FI940726 L FI 940726L FI 940726 A FI940726 A FI 940726A FI 940726 A FI940726 A FI 940726A FI 940726 L FI940726 L FI 940726L
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
FI940726A
Other languages
English (en)
Swedish (sv)
Other versions
FI940726A0 (fi
Inventor
Tudor Arvinte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI940726A0 publication Critical patent/FI940726A0/fi
Publication of FI940726L publication Critical patent/FI940726L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI940726A 1993-02-18 1994-02-16 Farmaseuttiset koostumukset FI940726L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303275A GB9303275D0 (en) 1993-02-18 1993-02-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI940726A0 FI940726A0 (fi) 1994-02-16
FI940726L true FI940726L (fi) 1994-08-19

Family

ID=10730651

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940726A FI940726L (fi) 1993-02-18 1994-02-16 Farmaseuttiset koostumukset

Country Status (21)

Country Link
US (1) US5472938A (fi)
EP (1) EP0624375B1 (fi)
JP (1) JP3649343B2 (fi)
CN (1) CN1108137A (fi)
AT (1) ATE216586T1 (fi)
AU (1) AU675471B2 (fi)
CA (1) CA2115815A1 (fi)
DE (1) DE69430458T2 (fi)
DK (1) DK0624375T3 (fi)
ES (1) ES2176222T3 (fi)
FI (1) FI940726L (fi)
GB (1) GB9303275D0 (fi)
HU (1) HUT66079A (fi)
IL (1) IL108610A (fi)
MX (1) MX9401244A (fi)
NO (1) NO940551D0 (fi)
NZ (1) NZ250895A (fi)
PH (1) PH30338A (fi)
PT (1) PT624375E (fi)
TW (1) TW315303B (fi)
ZA (1) ZA941087B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
WO1998031386A1 (fr) * 1997-01-20 1998-07-23 Japan Energy Corporation Procede de stabilisation de peptides et compositions medicinales lyophilisees comprenant des peptides obtenus par ce procede
NO20013182L (no) 2000-06-26 2001-12-27 Nokian Tyres Plc System og fremgangsmåte for konvertering og overföring av driftsdata for dekk
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487600A (en) * 1945-10-09 1949-11-08 Sharp & Dohme Inc Aqueous thixotropic gel composition
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
US2987600A (en) * 1959-03-11 1961-06-06 Corning Glass Works Capacitor edge sealing
CA1340646C (en) * 1987-05-21 1999-07-13 John L. Krstenansky Cyclic anticoagulant peptides
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
ZA941087B (en) 1994-08-18
HUT66079A (en) 1994-09-28
ATE216586T1 (de) 2002-05-15
DE69430458D1 (de) 2002-05-29
MX9401244A (es) 1994-08-31
EP0624375B1 (en) 2002-04-24
NO940551L (fi) 1994-08-19
EP0624375A2 (en) 1994-11-17
JPH06256214A (ja) 1994-09-13
DE69430458T2 (de) 2002-11-21
FI940726A0 (fi) 1994-02-16
TW315303B (fi) 1997-09-11
PT624375E (pt) 2002-08-30
PH30338A (en) 1997-04-02
AU675471B2 (en) 1997-02-06
NZ250895A (en) 1994-06-27
NO940551D0 (no) 1994-02-17
IL108610A0 (en) 1994-08-26
HU9400458D0 (en) 1994-05-30
CN1108137A (zh) 1995-09-13
CA2115815A1 (en) 1994-08-19
DK0624375T3 (da) 2002-07-29
EP0624375A3 (en) 1995-07-19
JP3649343B2 (ja) 2005-05-18
US5472938A (en) 1995-12-05
ES2176222T3 (es) 2002-12-01
AU5508394A (en) 1994-08-25
IL108610A (en) 1998-03-10
GB9303275D0 (en) 1993-04-07

Similar Documents

Publication Publication Date Title
FI944832A0 (fi) Farmaseuttinen koostumus
FI20071025L (fi) Farmaseuttisia koostumuksia
FI945524L (fi) Aerosolilääkekoostumuksia
FI955144A0 (fi) Päällystetyt farmaseuttiset koostumukset
IS4706A (is) Lyfjasamsetningar
DE69423670D1 (de) Siloxy-aluminoxan-Zusammensetzungen
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI922958L (fi) Farmaceutisk sammansaettning
FI981777L (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
NO20021172L (no) Farmasöytisk sammensetning
ITMI932540A0 (it) Composizione farmaceutica
MX9200622A (es) Composicion farmaceutica
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
FI943705L (fi) Farmaseuttiset koostumukset
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280L (fi) Farmaseuttinen koostumus
LV10579A (lv) Farmaceitiska kompozicija
FI940726L (fi) Farmaseuttiset koostumukset
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica
FI954050L (fi) Lääkekoostumuksia

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG